HYPRNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Hyperfine, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$0.78+0.02 (+2.97%)
Close on Oct 19, 2026
- Market cap
- $77.56M
- P/E (TTM)
- –
- Dividend yield
- –
Share price
−$0.5228 (−40.22%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.Earnings
Hyperfine, Inc. grew revenue 53.2% to $16.54M over the twelve months to Jun 30, 2026. Free cash flow was -$27.53M.
Revenue
$16.54M
+53.2% vs. a year earlier
Operating income
-$33.62M
TTM Q2 2026
Free cash flow
-$27.53M
TTM Q2 2026
EPS, diluted
-$0.38
TTM Q2 2026
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $77.56M
- P/E ratio
- –
- Price to sales
- 4.69
- Price to book
- 2.11
- Dividend yield
- –
- Free cash flow yield
- -35.49%
Fundamentals
- Revenue
- $16.54M
- Net income
- -$34.85M
- EPS, diluted
- -$0.38
- Free cash flow
- -$27.53M
- Book value per share
- $0.37
- Diluted shares
- 100M
Seven years at a glance
Fiscal years 2019 to 2025 and trailing twelve months, USD
Revenue
$16.54M+53.2% YoY
Gross profit
$8.50M+71.9% YoY
Operating income
-$33.62M
Net income
-$34.85M
EPS, diluted
-$0.38
Free cash flow
-$27.53M
Reported periodTrailing twelve months